LSX World Congress Europe 2026

Fish & Richardson Principal Madelyn McCormick will moderate the session “The Art of the Pitch: Communicating Commercial Potential to Investors" at LSX World Congress Europe on March 26 in Lisbon, Portugal.

Fish is a proud sponsor of LSX World Congress Europe, which gathers leaders in the biotech, medtech, and pharmaceutical sectors to shape the future of health care technology through meaningful discussion and collaboration. Session details are below.

The Art of the Pitch: Communicating Commercial Potential to Investors

While scientific innovation forms the foundation of biotech startups, effectively communicating commercial potential often determines which companies secure crucial investment. This dynamic panel explores how early-stage biotechs can craft compelling market narratives alongside their scientific breakthroughs. Industry experts will dissect how investors evaluate commercial viability in preclinical and Phase 1 assets, identify the critical slides and data points that strengthen pitch decks, and provide strategies for proactively addressing challenging commercial questions about adoption barriers.

• How do investors assess commercial potential in preclinical/Phase 1 assets?
• What slides/data matter most in a pitch deck?
• How can you address “showstopper" commercial questions (e.g., pricing, adoption barriers) head-on?

For more information, click here.